Anil Ltd net profit up 29% to Rs 11.74 crore in Q2 of FY12
Ahmedabad, November 10, 2011: Agro and food processing major, Anil Limited, reported a net profit of Rs 11.74 crore for [...]
Clinical Trial Endoints in Oncology – Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology
The primary endpoint for the approval of drugs in the oncology markets, which included colorectal, ovarian, head, neck and prostate [...]
Microbiology And Sterility Assurance In Pharmaceuticals And Medical Devices – New Book Released
Microbiology And Sterility Assurance In Pharmaceuticals And Medical Devices – New Book Released by Business Horizons the Pharmaceutical Publishers October [...]
Clinical Trials Asia Summit 2010
Clinical Trials Asia Summit 2010 will be held on August 19-20, 2010 at Taj Residency (M.G. Road), Bangalore, India Date [...]
GVK Biosciences Opens New Clinical Pharmacology Unit in Ahmedabad
GVK Biosciences Opens New Clinical Pharmacology Unit in Ahmedabad New Facility Commissioned to Meet Increasing Business Demand Hyderabad, India, March [...]
Pharmaceutical Pricing and Reimbursement – Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies
Twin pressures of global economic meltdown and spiraling healthcare costs have forced several countries to adopt a conservative approach towards [...]
Head and Neck Cancer – Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData expects the global head and neck cancer market to grow at 8.3% annually for the next seven years to [...]
Atrial Fibrillation – Drug Pipeline Analysis and Market Forecasts to 2016
The atrial fibrillation (AF) market is currently on the brink of rapid expansion due to the expected launch of novel [...]
Brain Tumor – Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData has estimated the global brain tumor market to be worth $1,094m in 2009 and forecasts it to grow at [...]
Asthma – Drug Pipeline Analysis and Market Forecasts to 2016
The global allergic rhinitis market was valued at $7 billion in 2009 and is forecast to decline by 2% annually [...]